ATE531717T1 - Neue kristalline form eines pyridazinoä4,5- büindolderivats - Google Patents
Neue kristalline form eines pyridazinoä4,5- büindolderivatsInfo
- Publication number
- ATE531717T1 ATE531717T1 AT06813757T AT06813757T ATE531717T1 AT E531717 T1 ATE531717 T1 AT E531717T1 AT 06813757 T AT06813757 T AT 06813757T AT 06813757 T AT06813757 T AT 06813757T AT E531717 T1 ATE531717 T1 AT E531717T1
- Authority
- AT
- Austria
- Prior art keywords
- büindol
- derivative
- crystalline form
- new crystalline
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71215305P | 2005-08-29 | 2005-08-29 | |
PCT/US2006/033254 WO2007027525A1 (en) | 2005-08-29 | 2006-08-24 | Novel crystalline form of a pyridazino [4 , 5-b] indole derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE531717T1 true ATE531717T1 (de) | 2011-11-15 |
Family
ID=37546937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06813757T ATE531717T1 (de) | 2005-08-29 | 2006-08-24 | Neue kristalline form eines pyridazinoä4,5- büindolderivats |
Country Status (32)
Country | Link |
---|---|
US (1) | US7683062B2 (de) |
EP (1) | EP1924585B1 (de) |
JP (1) | JP5063600B2 (de) |
KR (2) | KR20080050577A (de) |
CN (1) | CN101253176B (de) |
AR (1) | AR057099A1 (de) |
AT (1) | ATE531717T1 (de) |
AU (1) | AU2006285142B2 (de) |
BR (1) | BRPI0615259A2 (de) |
CA (1) | CA2619284C (de) |
CR (1) | CR9723A (de) |
CY (1) | CY1112317T1 (de) |
DK (1) | DK1924585T3 (de) |
EA (1) | EA014164B1 (de) |
EC (1) | ECSP088209A (de) |
ES (1) | ES2375841T3 (de) |
HK (1) | HK1123794A1 (de) |
HR (1) | HRP20120073T1 (de) |
IL (1) | IL189276A (de) |
MA (1) | MA30000B1 (de) |
NO (1) | NO20081365L (de) |
NZ (1) | NZ566087A (de) |
PL (1) | PL1924585T3 (de) |
PT (1) | PT1924585E (de) |
RS (1) | RS52318B (de) |
SI (1) | SI1924585T1 (de) |
TN (1) | TNSN08059A1 (de) |
TW (1) | TW200813060A (de) |
UA (1) | UA91716C2 (de) |
UY (1) | UY29771A1 (de) |
WO (1) | WO2007027525A1 (de) |
ZA (1) | ZA200801890B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007536210A (ja) * | 2003-11-17 | 2007-12-13 | メルック・エプロバ・アクチエンゲゼルシヤフト | (6r)−l−エリスロ−テトラヒドロビオプテリンジヒドロクロライドの結晶形 |
JP2008501657A (ja) * | 2004-06-02 | 2008-01-24 | サンド・アクチエンゲゼルシヤフト | 結晶形態のメロペネム中間体 |
BRPI0616040A2 (pt) * | 2005-09-21 | 2011-06-07 | Nycomed Gmbh | cloridrato de sulfonilpirról como inibidor de histona desacetilases |
EP1951700A2 (de) * | 2005-10-31 | 2008-08-06 | Janssen Pharmaceutica N.V. | Neue verfahren für die herstellung von piperazinyl- und diazapanylbenzamidderivaten |
EP2044020B1 (de) * | 2006-06-16 | 2011-05-04 | H. Lundbeck A/S | Kristalline formen von 4-[2-(4-methylphenylsulfanyl)phenyl]piperidin mit kombinierter serotonin- und norepinephrinwiederaufnahmehemmung zur behandlung neuropathischer schmerzen |
MX2009003913A (es) * | 2006-10-27 | 2009-04-24 | Signal Pharm Llc | Formas solidas que comprenden 4-[9-(tetrahidro-furano-3-il)-8-(2,4 ,6-trifluoro-fenilamino)-9h-purin-2-ilamino]-ciclohexan-1-ol, composiciones de las mismas, y su uso. |
EP2085397A1 (de) * | 2008-01-21 | 2009-08-05 | Esteve Quimica, S.A. | Kristalline Form von Abacavir |
US7935817B2 (en) * | 2008-03-31 | 2011-05-03 | Apotex Pharmachem Inc. | Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof |
AR071318A1 (es) * | 2008-04-15 | 2010-06-09 | Basilea Pharmaceutica Ag | Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso |
US8097719B2 (en) * | 2008-07-15 | 2012-01-17 | Genesen Labs | Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem |
KR20110052640A (ko) * | 2008-08-18 | 2011-05-18 | 사노피-아벤티스 유.에스. 엘엘씨 | 7-클로로-N,N,5-트리메틸-4-옥소-3-페닐-3,5-디하이드로-4H-피리다지노[4,5-b]인돌-1-아세트아미드의 다형체의 제조방법 |
NZ601967A (en) | 2010-03-12 | 2015-03-27 | Omeros Corp | Pde10 inhibitors and related compositions and methods |
EP2611433A2 (de) * | 2010-09-01 | 2013-07-10 | Arena Pharmaceuticals, Inc. | Nicht-hygroskopische salze aus 5-ht2c-agonisten |
WO2013044816A1 (en) * | 2011-09-30 | 2013-04-04 | Sunshine Lake Pharma Co., Ltd. | Crystalline forms of azilsartan and preparation and uses thereof |
NZ716462A (en) * | 2014-04-28 | 2017-11-24 | Omeros Corp | Optically active pde10 inhibitor |
NZ630810A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Processes and intermediates for the preparation of a pde10 inhibitor |
EP3285760A4 (de) | 2015-04-24 | 2018-09-26 | Omeros Corporation | Pde10-hemmer sowie entsprechende zusammensetzungen und verfahren |
JP2018535969A (ja) | 2015-11-04 | 2018-12-06 | オメロス コーポレーション | Pde10阻害剤の固体状態形態 |
CN111303230B (zh) * | 2020-03-09 | 2021-07-13 | 中国食品药品检定研究院 | 一种黄体酮共晶物及其制备方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2766823B1 (fr) * | 1997-07-30 | 1999-10-08 | Synthelabo | Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique |
FR2788696B1 (fr) * | 1999-01-26 | 2004-03-05 | Synthelabo | Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central |
FR2829939B3 (fr) | 2001-09-21 | 2003-11-28 | Sanofi Synthelabo | Utilisation du 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5- dihydro-4h-pyridazino(4,5-b)indole-1-acetamide pour la preparation de medicaments destines au traitement de la polyarthrite rhumatoide |
WO2005034999A2 (en) | 2003-10-10 | 2005-04-21 | Bvm Holding Co. | Composition comprising association complex of a pharmaceutical and a poloxamer |
-
2006
- 2006-08-24 UA UAA200803953A patent/UA91716C2/ru unknown
- 2006-08-24 ES ES06813757T patent/ES2375841T3/es active Active
- 2006-08-24 SI SI200631252T patent/SI1924585T1/sl unknown
- 2006-08-24 CA CA2619284A patent/CA2619284C/en not_active Expired - Fee Related
- 2006-08-24 NZ NZ566087A patent/NZ566087A/en not_active IP Right Cessation
- 2006-08-24 EA EA200800716A patent/EA014164B1/ru not_active IP Right Cessation
- 2006-08-24 KR KR1020087004953A patent/KR20080050577A/ko active IP Right Grant
- 2006-08-24 DK DK06813757.9T patent/DK1924585T3/da active
- 2006-08-24 JP JP2008529130A patent/JP5063600B2/ja not_active Expired - Fee Related
- 2006-08-24 AU AU2006285142A patent/AU2006285142B2/en not_active Ceased
- 2006-08-24 PT PT06813757T patent/PT1924585E/pt unknown
- 2006-08-24 KR KR1020137018636A patent/KR20130087059A/ko not_active Application Discontinuation
- 2006-08-24 PL PL06813757T patent/PL1924585T3/pl unknown
- 2006-08-24 EP EP06813757A patent/EP1924585B1/de active Active
- 2006-08-24 AT AT06813757T patent/ATE531717T1/de active
- 2006-08-24 BR BRPI0615259-7A patent/BRPI0615259A2/pt not_active IP Right Cessation
- 2006-08-24 RS RS20120032A patent/RS52318B/en unknown
- 2006-08-24 WO PCT/US2006/033254 patent/WO2007027525A1/en active Application Filing
- 2006-08-24 ZA ZA200801890A patent/ZA200801890B/xx unknown
- 2006-08-24 CN CN2006800314750A patent/CN101253176B/zh not_active Expired - Fee Related
- 2006-08-28 AR ARP060103740A patent/AR057099A1/es not_active Application Discontinuation
- 2006-08-29 TW TW095131681A patent/TW200813060A/zh unknown
- 2006-08-29 UY UY29771A patent/UY29771A1/es unknown
-
2008
- 2008-02-04 IL IL189276A patent/IL189276A/en not_active IP Right Cessation
- 2008-02-06 TN TNP2008000059A patent/TNSN08059A1/en unknown
- 2008-02-11 CR CR9723A patent/CR9723A/es unknown
- 2008-02-14 US US12/031,243 patent/US7683062B2/en not_active Expired - Fee Related
- 2008-02-20 EC EC2008008209A patent/ECSP088209A/es unknown
- 2008-03-14 NO NO20081365A patent/NO20081365L/no not_active Application Discontinuation
- 2008-03-17 MA MA30757A patent/MA30000B1/fr unknown
-
2009
- 2009-02-19 HK HK09101601.0A patent/HK1123794A1/xx not_active IP Right Cessation
-
2012
- 2012-01-23 HR HRP20120073TT patent/HRP20120073T1/hr unknown
- 2012-01-26 CY CY20121100092T patent/CY1112317T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE531717T1 (de) | Neue kristalline form eines pyridazinoä4,5- büindolderivats | |
LTC2343304I2 (lt) | Biocidiniai boronoftalido junginiai | |
DK1902037T3 (da) | 2,4-diamino-pyrimidiner som auroainhibitorer | |
ATE481383T1 (de) | 3-aza-bicycloä3.1.0ühexanderivate | |
ATE469145T1 (de) | 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl- | |
NL1031385A1 (nl) | Gesubstitueerde sulfonylaminoarylmethylcyclopropaancarbonamideverbindingen. | |
DE602005005306D1 (de) | Steuerung der Bahn eines Greifers | |
HRP20120323T1 (en) | Diarylhydantoin compounds | |
DK3275965T3 (da) | Sammensætninger, der omfatter en fluorolefin | |
BRPI0811718A2 (pt) | Derivados de 3,3-espiroindolinona | |
DE602006005030D1 (de) | Phasenaustauschtinten | |
ATE502012T1 (de) | 1,1,1-trifluor-2-hydroxy-3-phenylpropan-derivat | |
NL1031335A1 (nl) | Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen. | |
DE602007001681D1 (de) | 1,3-dioxan-carboxylsäuren | |
ATE487691T1 (de) | Acetylenderivate | |
NL1032046A1 (nl) | Prostaglandinederivaten. | |
BRPI0815059A2 (pt) | Derivado de 1,3-di-hidroisoindol | |
DK1963295T3 (da) | 3,6-dihydro-2-oxo-6H-(1,3,4)thiazinderivater | |
NL2000937A1 (nl) | Piperidinederivaten. | |
TWI315670B (en) | Substituted aryl 1,4-pyrazine derivatives | |
ATE445604T1 (de) | Neue 2,6-diaminopyridin-3-on-derivate | |
ITMO20050015A1 (it) | 'essiccatoio a spruzzo perfezionato. | |
BRPI0818848A2 (pt) | Compostos de 2,3-di-idro-benzofurano | |
DK1932835T3 (da) | Fremgangsmåde til fremstilling af 2,3-dihydropyridazinforbindelse | |
FR2871375B1 (fr) | Compositions tinctoriales comprenant un derive de 1,2-indanedione |